G786-2335 Screening compound: N-[3-(1,3-benzothiazol-2-yl)-6-(propan-2-yl)-4H,5H,6H,7H-thieno[2,3-c]pyridin-2-yl]-2-phenylacetamide

G786-2335 Screening compound: N-[3-(1,3-benzothiazol-2-yl)-6-(propan-2-yl)-4H,5H,6H,7H-thieno[2,3-c]pyridin-2-yl]-2-phenylacetamide
G786-2335 Screening compound: N-[3-(1,3-benzothiazol-2-yl)-6-(propan-2-yl)-4H,5H,6H,7H-thieno[2,3-c]pyridin-2-yl]-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G786-2335
N-[3-(1,3-benzothiazol-2-yl)-6-(propan-2-yl)-4H,5H,6H,7H-thieno[2,3-c]pyridin-2-yl]-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G786-2335

Molecular Formula

C25H25N3OS2 (C25 H25 N3 OS2)

Compound Name

N-[3-(1,3-benzothiazol-2-yl)-6-(propan-2-yl)-4H,5H,6H,7H-thieno[2,3-c]pyridin-2-yl]-2-phenylacetamide

IUPAC name

N-[3-(13-benzothiazol-2-yl)-6-(propan-2-yl)-4H5H6H7H-thieno[23-c]pyridin-2-yl]-2-phenylacetamide

SMILES

CC(C)N(CC1)Cc2c1c(-c1nc(cccc3)c3s1)c(NC(Cc1ccccc1)=O)s2

InChI

InChI=1S/C25H25N3OS2/c1-16(2)28-13-12-18-21(15-28)31-25(27-22(29)14-17-8-4-3-5-9-17)23(18)24-26-19-10-6-7-11-20(19)30-24/h3-11,16H,12-15H2,1-2H3,(H,27,29)

InChI Key

KYTBNQFAQDMKHH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11984346

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.63

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.541

Distribution Coefficient, logD

5.139

Water Solubility, LogSw

-5.48

Polar Surface Area

36.077

Acid Dissociation Constant (pKa)

8.61

Base Dissociation Constant (pKb)

7.58

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

G786-2335 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with G786-2335 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G786-2335?
Check Price and Availability of G786-2335, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G786-2335 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G786-2335
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G786-2335
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G786-2335 available by request